Skip to content

Dysfunctional Hemoglobin CO-ox

Dysfunctional Hemoglobin

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02427685
Enrollment
27
Registered
2015-04-28
Start date
2015-04-30
Completion date
2015-05-31
Last updated
2015-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated Levels of Carboxyhemoglobin

Brief summary

The study verifies accuracy of a new pulse co-oximeter in the presence of elevated carboxyhemoglobin levels.

Interventions

DEVICEPulse Co-Ox

Comparison of pulse co-oximeter to blood gas analyzer.

Sponsors

Nonin Medical, Inc
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* The subject is male or female. * The subject is of any racial or ethnic group. * The subject is between 18 years and 45 years of age. * The subject does not have significant medical problems. * The subject is willing to provide written informed consent and is willing and able to comply with study procedures.

Exclusion criteria

* Has a BMI greater than 31 * Has had any relevant injury at the sensor location site * Has deformities or abnormalities that may prevent proper application of the device under test. * Has a known respiratory condition. * Is currently a smoker. * Has a known heart or cardiovascular condition. * Is currently pregnant. * Is female and actively trying to get pregnant. * Has a clotting disorder. * Has Raynaud's Disease. * Is known to have a hemoglobinopathy such as (anemia, bilirubinemia, sickle-cell anemia, inherited or congenital methemoglobinemia). * The subject has a COHb greater than 3% or MetHb greater than 2%. * Has taken blood thinners or medication with aspirin within the last 24 hours. * Has unacceptable collateral circulation from the ulnar artery. * Has donated more than 300 mL of blood within one month prior to start of study. * Is unwilling or unable to provide written informed consent to participate in the study. * Is unwilling or unable to comply with the study procedures for the primary objectives. * Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.

Design outcomes

Primary

MeasureTime frame
Carboxyhemoglobin over the range of 0-15 percent as assessed by co-oximetry.3 hours

Secondary

MeasureTime frame
Oxygen saturation accuracy in conditions of elevated carboxyhemoglobin.3 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026